SCHEMBL12458474

SCHEMBL12458474

CCCCCCCC/C=C/CN(CCCC)CCCCN(C/C=C/CCCCCCCC)CCCC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 6/20 0.49
FAAH O00519 4/20 0.48
TRPV1 Q8NER1 1/20 0.48
EPHX2 P34913 4/20 0.44
TERT O14746 3/20 0.42
MAPT P10636 2/20 0.42
BLM P54132 2/20 0.42
HSD17B10 Q99714 2/20 0.42
FABP4 P15090 2/20 0.42
GMNN O75496 1/20 0.42
USP2 O75604 1/20 0.42
LMNA P02545 1/20 0.42
CYP1A2 P05177 1/20 0.42
POLB P06746 1/20 0.42
CYP2C9 P11712 1/20 0.42
ALOX15 P16050 1/20 0.42
APEX1 P27695 1/20 0.42
CYP2C19 P33261 1/20 0.42
RECQL P46063 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10909090 0.98 KCNH2 (0.50) KCNH2FAAHTRPV1EPHX2TERT
SCHEMBL10065914 0.89 FAAH (0.54) KCNH2FAAHTRPV1EPHX2TERT
SCHEMBL15534858 0.89 FAAH (0.54) KCNH2FAAHTRPV1EPHX2TERT
SCHEMBL12458477 0.89 FAAH (0.54) KCNH2FAAHTRPV1EPHX2TERT
SCHEMBL18525113 0.89 FAAH (0.54) KCNH2FAAHTRPV1EPHX2TERT
SCHEMBL25382057 0.89 FAAH (0.54) KCNH2FAAHTRPV1EPHX2TERT
SCHEMBL4950503 0.89 FAAH (0.54) KCNH2FAAHTRPV1EPHX2TERT
SCHEMBL11686302 0.89 KCNH2 (0.53) KCNH2
SCHEMBL11683035 0.89 KCNH2 (0.53) KCNH2
SCHEMBL9016980 0.89 KCNH2 (0.53) KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120238747-A1 TRANSFECTION REAGENTS Life Technologies Corporation (US) 2012-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120238747-A1 TRANSFECTION REAGENTS CPS1, PHAX, HNRNPH3 KCNH2 400/4885FAAH 4748/4885TRPV1 3137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.